Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ME-401 and R-CHOP in newly diagnosed DLBCL
NCT04517435Phase 2Terminated
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zandelisib in diffuse large B-cell lymphoma (DLBCL). Started Apr 2021; status: terminated.
02
Drugs
zandelisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04517435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04517435.